The hearing implant maker’s shares cratered to the lowest level since April 2016 amid the Middle East conflict and plunging ...
Envoy Medical Inc, a hearing health company pioneering fully implanted hearing solutions, announced that all 56 patients implanted and enrolled in its pivotal clinical trial evaluating the fully ...
All 56 Enrolled Subjects Have Been Through Their Activation Visit Firming Up Study TimelineWhite Bear Lake, Minnesota--(Newsfile Corp. - April 22, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy ...
Cochlear’s shares have collapsed after the hearing implants behemoth again downgraded profit guidance by up to $170m on ...
Cochlear also said that trading conditions for implants in developed markets have been softer-than-expected, while the fourth ...
Oklahoma boy hears clearly for the first time with cochlear implant ...
WHITE BEAR LAKE, Minn. - Envoy Medical, Inc. (NASDAQ:COCH) announced that the first three patients in its pivotal clinical trial for the Acclaim cochlear implant completed their 12-month endpoint ...
The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, ...
MedPage Today on MSN
First Gene Therapy Approved for Hearing Loss
Maker says Otarmeni will be offered for free in the U.S.
The US Food and Drug Administration on Thursday approved the first gene therapy for inherited hearing loss, a one-time ...
Otarmeni, now cleared to treat a rare, inherited kind of hearing loss, is the first gene therapy cleared under the FDA’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results